Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 31(10): 2037-2047, 2017 10.
Article in English | MEDLINE | ID: mdl-28074072

ABSTRACT

Inhibition of anti-apoptotic BCL-2 (B-cell lymphoma 2) has recently emerged as a promising new therapeutic strategy for the treatment of a variety of human cancers, including leukemia. Here, we used T-cell acute lymphoblastic leukemia (T-ALL) as a model system to identify novel synergistic drug combinations with the BH3 mimetic venetoclax (ABT-199). In vitro drug screening in primary leukemia specimens that were derived from patients with high risk of relapse or relapse and cell lines revealed synergistic activity between venetoclax and the BET (bromodomain and extraterminal) bromodomain inhibitor JQ1. Notably, this drug synergism was confirmed in vivo using T-ALL cell line and patient-derived xenograft models. Moreover, the therapeutic benefit of this drug combination might, at least in part, be mediated by an acute induction of the pro-apoptotic factor BCL2L11 and concomitant reduction of BCL-2 upon BET bromodomain inhibition, ultimately resulting in an enhanced binding of BIM (encoded by BCL2L11) to BCL-2. Altogether, our work provides a rationale to develop a new type of targeted combination therapy for selected subgroups of high-risk leukemia patients.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Azepines/pharmacology , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Molecular Targeted Therapy , Neoplasm Proteins/antagonists & inhibitors , Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , Sulfonamides/pharmacology , Triazoles/pharmacology , Animals , Azepines/administration & dosage , Bcl-2-Like Protein 11/biosynthesis , Bcl-2-Like Protein 11/genetics , Bridged Bicyclo Compounds, Heterocyclic/administration & dosage , Cell Cycle Proteins , Cell Line, Tumor , Drug Synergism , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Mice , Mice, Inbred NOD , Mice, SCID , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Nuclear Proteins/antagonists & inhibitors , Protein Domains , Sulfonamides/administration & dosage , Transcription Factors/antagonists & inhibitors , Triazoles/administration & dosage , Xenograft Model Antitumor Assays
3.
Cell Mol Life Sci ; 62(11): 1260-6, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15905959

ABSTRACT

A key regulatory mechanism in cell motility is the control of myosin activity, which in non-muscle cells is determined by phosphorylation of the myosin regulatory light chain (MRLC). Here we show that MRLC-interacting protein (MIR)-interacting saposin-like protein (MSAP) enhances cell spreading in fibroblasts and migration of rat C6 glioma cells through increases in MRLC phosphorylation. Overexpression of MSAP enhanced the motility of glioma cells measured in matrigel invasion chambers and using a scratch assay. Downregulation of MSAP by RNA interference significantly decreased glioma cell migration and phosphorylation of MRLC. Inhibition of the corresponding MRLC kinase by ML-7 did not affect migration of MSAP-overexpressing cells. The present results show that MSAP controls glioma cell migration via enhancement of MRLC phosphorylation. This effect is independent of the activity of MRLC kinase. Thus, MSAP is a novel modulator of cell motility that influences migration of glioma cells and possibly other tumors.


Subject(s)
Carrier Proteins/physiology , Cell Movement/drug effects , Glioma/physiopathology , Myosin Light Chains/metabolism , Saposins/pharmacology , 3T3 Cells , Animals , Carrier Proteins/genetics , Carrier Proteins/metabolism , Cell Line, Tumor , Cell Movement/physiology , Fibroblasts/cytology , Fibroblasts/drug effects , Glioma/drug therapy , Glioma/pathology , Mice , Myosin Light Chains/drug effects , Phosphorylation , RNA Interference/physiology , RNA, Small Interfering/pharmacology , Rats , Saposins/antagonists & inhibitors , Saposins/metabolism
4.
J Comp Neurol ; 422(4): 594-611, 2000 Jul 10.
Article in English | MEDLINE | ID: mdl-10861528

ABSTRACT

The cellular distribution of utrophin, the autosomal homologue of dystrophin, was investigated in developing and adult rat and mouse brain by in situ hybridization and immunohistochemistry. Digoxigenin-labeled cRNA probes complementary to N-terminal, rod-domain, and C-terminal encoding sequences of utrophin were used to differentiate between full-length and short C-terminal isoforms. Largely overlapping distribution patterns were seen for the three probes in neurons of cerebral cortex, accessory olfactory bulb, and several sensory and motor brainstem nuclei as well as in blood vessels, pia mater, and choroid plexus. The C-terminal probe was detected in addition in the main olfactory bulb, striatum, thalamic reticular nucleus, and hypothalamus, suggesting a selective expression of G-utrophin in these neurons. Western blot analysis with isoform-specific antisera confirmed the expression of both full-length and G-utrophin in brain. Immunohistochemically, only full-length utrophin was detected in neurons, in close association with the plasma membrane. In addition, intense staining was seen in blood vessels, meninges, and choroid plexus, selectively localized in the basolateral membrane of immunopositive epithelial cells. The expression pattern of utrophin was already established at early postnatal stages and did not change thereafter. Double-labeling analysis revealed that utrophin and dystrophin are differentially expressed on the cellular and subcellular levels in juvenile and adult brain. Likewise, in mice lacking full-length dystrophin isoforms (mdx mice), no change in utrophin expression and distribution could be detected in brain, although utrophin was markedly up-regulated in muscle cells. These results suggest that utrophin and dystrophin are independently regulated and have distinct functional roles in CNS neurons.


Subject(s)
Brain/metabolism , Cytoskeletal Proteins/metabolism , Dystrophin/metabolism , Membrane Proteins/metabolism , Neurons/metabolism , Age Factors , Animals , Immunohistochemistry , In Situ Hybridization , Mice , Mice, Inbred C57BL , Muscle Fibers, Skeletal/metabolism , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Utrophin
5.
J Cell Biochem ; 77(3): 418-31, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10760950

ABSTRACT

Dystrophin and utrophin are known to link the intracellular cytoskeleton to the extracellular matrix via a transmembraneous glycoprotein complex. Four short C-terminal isoforms (Dp71, Dp116, Dp140, and Dp260) are described for dystrophin and three for utrophin (Up71, Up113, and Up140). We describe here for the first time the existence of a 3.7-kb transcript and a 62-kDa protein in C6 glioma cells representing a short N-terminal isoform unique for utrophin (N-utrophin). More than 20 clones covering the entire coding region of utrophin were isolated from a rat C6 glioma cell cDNA library. Two clones were found to code for a protein with 539 amino acids. Its sequence is identical to that of the full-length utrophin, except for the last residue where Cys is replaced by Val. This isoform contains the actin binding domain (consisting of two calponin homology subdomains), followed by two spectrin-like repeats. A recombinant fragment corresponding to N-utrophin binds to F-actin in vitro with an equilibrium constant (affinity) K of 4.5 x 10(5) M(-1) and a stoichiometry of one fragment per around five actin monomers. Immunocytochemical staining of C6 glioma cells with antisera specific for different utrophin regions localised full-length utrophin in the submembraneous cortical actin layer as revealed by confocal microscopy. A distinct staining pattern for the N-utrophin was not detectable, although it was expected to localise at the actin stress fibers. It is assumed that it co-localises via the two spectrin-like repeats with the full-length utrophin at the cell membrane.


Subject(s)
Cytoskeletal Proteins/chemistry , Membrane Proteins/chemistry , Actins/metabolism , Animals , Blotting, Northern , Blotting, Western , Cloning, Molecular , Cytoskeletal Proteins/biosynthesis , Cytoskeletal Proteins/genetics , DNA, Complementary/metabolism , Diaphragm/metabolism , Dystrophin/metabolism , Gene Library , Immunohistochemistry , Kidney/metabolism , Lung/metabolism , Membrane Proteins/biosynthesis , Membrane Proteins/genetics , Microscopy, Confocal , Protein Binding , Protein Structure, Tertiary , RNA, Messenger/metabolism , Rats , Recombinant Proteins/metabolism , Tumor Cells, Cultured , Utrophin
6.
Biochem Biophys Res Commun ; 279(3): 879-83, 2000 Dec 29.
Article in English | MEDLINE | ID: mdl-11162443

ABSTRACT

The ERM proteins, ezrin, radixin, and moesin, regulate cell motility by linking cortical F-actin to the plasma membrane in different cell types. Myosin regulatory light chain interacting protein (MIR) is a recently cloned ERM-like protein which was shown to be involved in neurite outgrowth. Here we have studied the occurrence and expression of MIR in rats during brain development. As shown using Western blotting, MIR is present in different regions both in developing and adult brain. Immunohistochemistry and double labelling studies showed that MIR is localized especially to neurons in hippocampus and cerebellum. A search using the gene bank showed that the MIR gene localised to human chromosome 6 in the interval 6p22.3-23, the loss of which is characterized by mental retardation and different malformations in man. The presence of MIR in brain neurons during development together with its known effects on neurite outgrowth suggest an important function of the protein in the regulation of nerve cell motility and cytoskeletal interactions.


Subject(s)
Brain/metabolism , Carrier Proteins/metabolism , Chromosomes, Human, Pair 6 , Neurons/metabolism , Animals , Carrier Proteins/genetics , Chromosome Mapping , DNA-Binding Proteins/chemistry , Genome, Human , Humans , Immunohistochemistry , Rats , Rats, Wistar , Tissue Distribution , Transcription Factors/chemistry , Ubiquitin-Protein Ligases
7.
Cell Tissue Res ; 287(1): 211-21, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9011397

ABSTRACT

The distribution of histamine-like immunoreactivity has been analyzed in the visual system and brain of the cricket Gryllus campestris and of the bee Apis mellifera by using an antiserum against histamine. Specific immunolabeling of the photoreceptors has been found in the compound eyes and ocelli of both examined species. Intense immunostaining can be also detected in the midbrain of these species. The axons of immunoreactive cells innervate almost every area in the protocerebrum. Most of the reactive neurons are typically wide-field neurons with bilateral ramifications that form dense arborizations. Numerous small buttons on the arborizations probably represent pre- and postsynaptic sites. The histamine-like immunoreactive neurons are apparently connected to many postsynaptic neurons. In both bees and crickets, some regions of the nervous system such as the first two optic neuropils and the central body show the same labeling pattern, whereas the mushroom bodies exhibit no immunoreactivity. Nevertheless, several differences in the staining pattern can be seen: the glomeruli of the antennal lobe are invaded by histamine-like immunoreactive fibers in the bee but not in the cricket. Furthermore, an interneuron connects the second and third optic neuropil in the cricket, whereas no histamine-like immunoreactive interneuron is found in the second optic neuropil in the bee. In accord with the work of other authors on the distribution histamine in the insect nervous system, we suggest that histamine is not only a transmitter within the visual system, but also a transmitter or co-transmitter in the insect midbrain.


Subject(s)
Bees/metabolism , Gryllidae/metabolism , Histamine/metabolism , Animals , Brain/metabolism , Neurons/metabolism , Optic Lobe, Nonmammalian/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...